Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH – Free Report) – HC Wainwright decreased their FY2023 earnings estimates for shares of Longboard Pharmaceuticals in a report issued on Monday, January 8th. HC Wainwright analyst P. Trucchio now expects that the company will post earnings per share of ($2.28) for the year, down from their previous estimate of ($2.14). […]
Longboard Pharmaceuticals (NASDAQ:LBPH – Free Report) had its price target boosted by HC Wainwright from $25.00 to $60.00 in a report published on Monday morning, Benzinga reports. They currently have a buy rating on the stock. HC Wainwright also issued estimates for Longboard Pharmaceuticals’ Q4 2023 earnings at ($0.52) EPS, FY2023 earnings at ($2.28) EPS, […]
Shares of Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH – Get Free Report) gapped down before the market opened on Friday . The stock had previously closed at $24.85, but opened at $23.79. Longboard Pharmaceuticals shares last traded at $24.55, with a volume of 64,839 shares trading hands. Wall Street Analysts Forecast Growth LBPH has been the subject […]
Cantor Fitzgerald reissued their overweight rating on shares of Longboard Pharmaceuticals (NASDAQ:LBPH – Free Report) in a research note issued to investors on Tuesday morning, Benzinga reports. The firm currently has a $35.00 price objective on the stock, up from their previous price objective of $16.00. Cantor Fitzgerald also issued estimates for Longboard Pharmaceuticals’ FY2023 […]
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH – Get Free Report) was the recipient of a significant decline in short interest during the month of September. As of September 15th, there was short interest totalling 569,600 shares, a decline of 10.1% from the August 31st total of 633,900 shares. Approximately 3.1% of the shares of the company are […]